Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
APGAR ScoreAssisted Delivery (FIGO)BPP (Manning Score)Bishop ScoreCARPREG II Cardiac RiskCervical Cancer StagingContraceptive Pearl IndexDoppler Matrix (UA/MCA)EFW (Hadlock)Endometrial StagingEndometrial ThicknessFGR Criteria (Consensus)FSFI (Sexual Function)Ferriman-Gallwey ScoreFetal Anemia (MCA PSV)GDM Diagnostic CriteriaGPA History IndicatorGail Model Breast RiskGestational Dating (LMP)HIV PMTCT ProtocolIOTA Simple RulesIVF Due Date & AMHIron Deficit (Ganzoni)Labour Progress (WHO)Maternal Sepsis (qSOFA)O-RADS ClassificationOvarian Cancer StagingPAS Hemorrhage RiskPPH Protocol (FIGO)Preeclampsia (ACOG)Rho(D) Dose (K-B)Rotterdam PCOS CriteriaSyphilis ManagementTORCH FrameworkVBAC Success ProbabilityVulvar Cancer StagingWeight Gain (IOM)mWHO Cardiac Risk
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

HIV PMTCT Protocol

HIV Management (PMTCT)

Prevention of Mother-to-Child Transmission

Standard of Care
  • Immediate initiation of Triple ART
  • Target VL: Undetectable at 36w
  • Infant Post-exposure Prophylaxis
  • Avoid prolonged ROM during labour
Mode of Delivery Criteria

Vaginal Delivery Safe

Viral Load < 50 copies/mL

Elective C-Section Indic.

Viral Load > 1000 copies/mL

Reference: WHO PMTCT Integrated Guidelines / CDC HIV Prevention Framework.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Primary Clinical Uses

Guiding the mode of delivery (Vaginal vs Cesarean) in pregnant individuals living with HIV.
Determining the necessity for intrapartum intravenous Zidovudine (AZT).
Preventing Mother-to-Child Transmission (PMTCT) of HIV during labor and delivery.

Success Rate

With strict adherence to antiretroviral therapy (ART) and an undetectable viral load appropriately managed at delivery, the perinatal transmission rate of HIV drops from ~25% to less than 1%.

Last Comprehensive Review: 2026